Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, August 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 323 articles:
HTML format


 

Single Articles

  1. BIZZARRI N, Boldrini L, Ferrandina G, Fanfani F, et al
    Radiomic models for lymph node metastasis prediction in cervical cancer: can we think beyond sentinel lymph node?
    Transl Oncol. 2021;14:101185.
    PubMed    
    Abstract available

  2. ZHANG Q, Zong L, Zhang H, Xie W, et al
    Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer.
    Onco Targets Ther. 2021;14:4275-4283.
    PubMed    
    Abstract available

  3. SRIPAN P, Chitapanarux I, Tharavichitkul E, Muangwong P, et al
    Disparities in the change of cervical cancer mortality rate between urban and rural Chiang Mai in the era of universal health care and the Thai national screening program.
    Int J Equity Health. 2021;20:175.
    PubMed    
    Abstract available

  4. HAN Y, Ji L, Guan Y, Ma M, et al
    An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.
    Clin Transl Med. 2021;11:e498.
    PubMed    
    Abstract available

  5. WANG X, Sun H, Zhu S
    Long non-coding RNA PTAR inhibits apoptosis but promotes proliferation, invasion and migration of cervical cancer cells by binding miR-101.
    Bioengineered. 2021;12:4536-4545.
    PubMed    
    Abstract available

  6. TURAN I, Demir S, Yaman SO, Canbolat D, et al
    An Investigation of the Antiproliferative Effect of Rhododendron luteum Extract on Cervical Cancer (HeLa) Cells via Nrf2 Signaling Pathway.
    Nutr Cancer. 2021 Jul 29:1-12. doi: 10.1080/01635581.2021.1955287.
    PubMed    
    Abstract available

  7. DOZIE UW, Ebirim CIC, Dike CR, Dozie INS, et al
    Determinants of cervical cancer screening uptake among female undergraduates in a tertiary institution in south eastern Nigeria: a cross sectional study.
    J Prev Med Hyg. 2021;62:E213-E221.
    PubMed    
    Abstract available

  8. DU W, Wang Y, Li D, Xia X, et al
    Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics -Based Nomogram.
    Front Oncol. 2021;11:637794.
    PubMed    
    Abstract available

  9. KONG W, Zhao G, Chen H, Wang W, et al
    Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment.
    Cancer Cell Int. 2021;21:399.
    PubMed    
    Abstract available

  10. ZHOU Y, Wang Y, Lin M, Wu D, et al
    LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells.
    Cancer Cell Int. 2021;21:400.
    PubMed    
    Abstract available

  11. TAPERA O, Nyakabau AM, Simango N, Guzha BT, et al
    Gaps and opportunities for cervical cancer prevention, diagnosis, treatment and care: evidence from midterm review of the Zimbabwe cervical Cancer prevention and control strategy (2016-2020).
    BMC Public Health. 2021;21:1478.
    PubMed    
    Abstract available

  12. SASAKI A, Nakao Y, Obara T, Abe S, et al
    Knowledge and Attitude towards Cervical Cancer and Human Papillomavirus among Pharmacists in Japan.
    Asian Pac J Cancer Prev. 2021;22:2259-2265.
    PubMed    
    Abstract available

  13. IVY SC, Shabnaz S, Shahriar M, Jafrin S, et al
    Association of RAD51 and XRCC2 Gene Polymorphisms with Cervical Cancer Risk in the Bangladeshi Women.
    Asian Pac J Cancer Prev. 2021;22:2099-2107.
    PubMed    
    Abstract available

  14. DAVIES-OLIVEIRA JC, Smith MA, Grover S, Canfell K, et al
    Eliminating Cervical Cancer: Progress and Challenges for High-income Countries.
    Clin Oncol (R Coll Radiol). 2021 Jul 24. pii: S0936-6555(21)00258.
    PubMed    
    Abstract available

  15. HARUYAMA R, Nyahoda M, Kapambwe S, Sugiura Y, et al
    Underreported Breast and Cervical Cancer Deaths Among Brought-In-Dead Cases in Zambia.
    JCO Glob Oncol. 2021;7:1209-1211.
    PubMed    
    Abstract available

  16. OKOLIE EA, Barker D, Nnyanzi LA, Anjorin S, et al
    Factors influencing cervical cancer screening practice among female health workers in Nigeria: A systematic review.
    Cancer Rep (Hoboken). 2021 Jul 27:e1514. doi: 10.1002/cnr2.1514.
    PubMed    
    Abstract available

  17. DAI M, Song J, Wang L, Zhou K, et al
    HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through beta-catenin/c-Myc signaling pathway.
    J Bioenerg Biomembr. 2021 Jul 26. pii: 10.1007/s10863-021-09908.
    PubMed    
    Abstract available

  18. NIU Z, Wang F, Lv S, Lv Y, et al
    HNRNPU-AS1 regulates cell proliferation and apoptosis via miR-205-5p/AXIN2 axis and Wnt/beta-catenin signaling pathway in cervical cancer.
    Mol Cell Biol. 2021 Jul 26:MCB0011521. doi: 10.1128/MCB.00115.
    PubMed    
    Abstract available

  19. LIU S, Li B, Li Y, Song H, et al
    Circular RNA circ_0000228 promotes the malignancy of cervical cancer via microRNA-195-5p/ lysyl oxidase-like protein 2 axis.
    Bioengineered. 2021;12:4397-4406.
    PubMed    
    Abstract available

  20. DROKOW EK, Effah CY, Agboyibor C, Sasu E, et al
    The Impact of Video-Based Educational Interventions on Cervical Cancer, Pap Smear and HPV Vaccines.
    Front Public Health. 2021;9:681319.
    PubMed    
    Abstract available

  21. SUN J, Yue Y, Li R, Sun Q, et al
    Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
    Am J Transl Res. 2021;13:7312-7317.
    PubMed    
    Abstract available

  22. TIAN M, Fu H, Du J
    Application value of NRS2002 and PG-SGA in nutritional assessment for patients with cervical cancer surgery.
    Am J Transl Res. 2021;13:7186-7192.
    PubMed    
    Abstract available

  23. HAN D, Wang D, Yang J, Li X, et al
    Effect of multidisciplinary collaborative continuous nursing on the psychological state and quality of life of patients with cervical cancer.
    Am J Transl Res. 2021;13:6654-6661.
    PubMed    
    Abstract available

  24. SHA J, Du J, Yang J, Hu X, et al
    Changes of serum levels of tumor necrosis factor (TNF-alpha) and soluble interleukin-2 receptor (SIL 2R) in patients with cervical cancer and their clinical significance.
    Am J Transl Res. 2021;13:6599-6604.
    PubMed    
    Abstract available

  25. HE X, Wang Y, Ping J, Xu W, et al
    The serum CK17 and CK19 expressions in cervical cancer patients and their prognostic value.
    Am J Transl Res. 2021;13:6439-6445.
    PubMed    
    Abstract available

  26. SHI X, Ma L, Hao J, Yan W, et al
    Regulatory effects of comprehensive psychological intervention on adverse emotions and immune status of cervical cancer patients during the perioperative period.
    Am J Transl Res. 2021;13:6362-6371.
    PubMed    
    Abstract available

  27. WANG Z, Chen Y, Wang W, Wang H, et al
    circMYC promotes cell proliferation, metastasis, and glycolysis in cervical cancer by up-regulating MET and sponging miR-577.
    Am J Transl Res. 2021;13:6043-6054.
    PubMed    
    Abstract available

  28. MA R, Alifu N, Du Z, Chen S, et al
    Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer.
    Int J Nanomedicine. 2021;16:4847-4861.
    PubMed    
    Abstract available

  29. JOHN LIM BB, Yong CM
    Retrospective study of pelvic and para-aortic lymph nodes positivity in stage 1A to 2A cervical cancer patients.
    Med J Malaysia. 2021;76:534-540.
    PubMed    
    Abstract available

  30. MATSUO K, Huang Y, Matsuzaki S, Deshpande RR, et al
    Association between hysterectomy wait-time and all-cause mortality for micro-invasive cervical cancer: treatment implications during the coronavirus pandemic.
    Arch Gynecol Obstet. 2021 Jul 23. pii: 10.1007/s00404-021-06151.
    PubMed    


  31. CHARRA-BRUNAUD C, Salleron J, Menoux I, Peignaux K, et al
    [Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial].
    Cancer Radiother. 2021 Jul 20. pii: S1278-3218(21)00129.
    PubMed    
    Abstract available

  32. TAFERE Y, Jemere T, Desalegn T, Melak A, et al
    Women's knowledge and attitude towards cervical cancer preventive measures and associated factors In South Gondar Zone, Amhara Region, North Central Ethiopia: a cross-sectional study.
    Arch Public Health. 2021;79:136.
    PubMed    
    Abstract available

  33. MARQUES P, Gama A, Santos M, Heleno B, et al
    Understanding Cervical Cancer Screening Barriers among Migrant Women: A Qualitative Study with Healthcare and Community Workers in Portugal.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  34. LEN JM, Hussein N, Malla S, Mcintosh K, et al
    A Novel Dialkylamino-Functionalized Chalcone, DML6, Inhibits Cervical Cancer Cell Proliferation, In Vitro, via Induction of Oxidative Stress, Intrinsic Apoptosis and Mitotic Catastrophe.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  35. CHUGUNOVA E, Micheletti G, Telese D, Boga C, et al
    Novel Hybrid Compounds Containing Benzofuroxan and Aminothiazole Scaffolds: Synthesis and Evaluation of Their Anticancer Activity.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  36. CURTY G, Menezes AN, Brant AC, de Mulder Rougvie M, et al
    Expression of Retroelements in Cervical Cancer and Their Interplay with HPV Infection and Host Gene Expression.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  37. VILASBOAS-RIBEIRO I, Curto S, van Rhoon GC, Franckena M, et al
    MR Thermometry Accuracy and Prospective Imaging-Based Patient Selection in MR-Guided Hyperthermia Treatment for Locally Advanced Cervical Cancer.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  38. LI X, Zhang Q, Chen G, Luo D, et al
    Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC(+) and SPP1(+) TAMs in Cervical Cancer.
    Front Immunol. 2021;12:694801.
    PubMed    
    Abstract available

  39. DUSHKIN AD, Afanasiev MS, Zatevalov AM, Aleshkin VA, et al
    Digital analysis and quantitative assessment of the cervical surface with dysplasia.
    Klin Lab Diagn. 2021;66:417-421.
    PubMed    
    Abstract available

  40. RAFFERTY H, Sturt AS, Phiri CR, Webb EL, et al
    Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women.
    BMC Infect Dis. 2021;21:691.
    PubMed    
    Abstract available

  41. JIN R, Yang X, Bao J, Zhang W, et al
    The prevalence and genotype distribution of human papilloma virus in cervical squamous intraepithelial lesion and squamous cell carcinoma in Taizhou, China.
    Medicine (Baltimore). 2021;100:e26593.
    PubMed    
    Abstract available

  42. XU L, Song J
    Elevated neutrophil-lymphocyte ratio can be a biomarker for predicting the development of cervical intraepithelial neoplasia.
    Medicine (Baltimore). 2021;100:e26335.
    PubMed    
    Abstract available

  43. HILLEMANNS P, Kampers J, Hachenberg J, Jentschke M, et al
    [Vaccination against human papillomavirus].
    Internist (Berl). 2021;62:816-826.
    PubMed    
    Abstract available

  44. CEJA-FDEZ A, Carriles R, Gonzalez-Yebra AL, Vivero-Escoto J, et al
    Imaging and SERS Study of the Au Nanoparticles Interaction with HPV and Carcinogenic Cervical Tissues.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  45. MEGGETTO O, Jembere N, Gao J, Walker MJ, et al
    The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
    BJOG. 2021;128:1503-1510.
    PubMed    
    Abstract available

  46. PORTNOY A, Sweet S, Desalegn D, Memirie ST, et al
    Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study.
    Health Policy Plan. 2021;36:891-899.
    PubMed    
    Abstract available

  47. BONJOUR M, Charvat H, Franco EL, Pineros M, et al
    Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis.
    Lancet Public Health. 2021;6:e510-e521.
    PubMed    
    Abstract available

  48. MCGOVERN J, Fuller C, Burris K
    Anal cancer screening and prevention: a review for dermatologists.
    J Eur Acad Dermatol Venereol. 2021;35:1622-1627.
    PubMed    
    Abstract available

  49. LUO H, Yao H, Xu X, Li Z, et al
    Prognostic significance of poorly differentiated histology and impact of adjuvant chemotherapy in early squamous cell carcinoma of cervix uteri.
    Cancer Med. 2021;10:2611-2617.
    PubMed    
    Abstract available

  50. REUTER C, Preece M, Banwait R, Boer S, et al
    Consistency of the S5 DNA methylation classifier in formalin-fixed biopsies versus corresponding exfoliated cells for the detection of pre-cancerous cervical lesions.
    Cancer Med. 2021;10:2668-2679.
    PubMed    
    Abstract available

  51. QIAN H, Cheng Q, Tian Y, Dang H, et al
    An anti-aggregation NIR-II heptamethine-cyanine dye with a stereo-specific cyanine for imaging-guided photothermal therapy.
    J Mater Chem B. 2021;9:2688-2696.
    PubMed    
    Abstract available

  52. CHEN Z, Dong D, Zhu Y, Pang N, et al
    The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
    FASEB J. 2021;35:e21401.
    PubMed    
    Abstract available

  53. KE J, Shen Y, Lu Y, Deng J, et al
    Quantitative analysis of abnormalities in gynecologic cytopathology with deep learning.
    Lab Invest. 2021;101:513-524.
    PubMed    
    Abstract available

  54. TEOMAN G, Ersoz S
    Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix: A case report.
    Indian J Pathol Microbiol. 2021;64:174-176.
    PubMed    
    Abstract available

  55. DUONG HT, Hopfer S
    "Let's Chat": process evaluation of an intergenerational group chat intervention to increase cancer prevention screening among Vietnamese American families.
    Transl Behav Med. 2021;11:891-900.
    PubMed    
    Abstract available

  56. MILLS AM
    PD-L1 Interpretation in Cervical Carcinomas: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
    Int J Gynecol Pathol. 2021;40:1-4.
    PubMed    


  57. CHAN DNS, So WKW
    Effectiveness of motivational interviewing in enhancing cancer screening uptake amongst average-risk individuals: A systematic review.
    Int J Nurs Stud. 2021;113:103786.
    PubMed    
    Abstract available

  58. WOHLMUTH C, Ghorab Z, Shier M, Tinmouth J, et al
    Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer.
    Cancer Cytopathol. 2021;129:140-147.
    PubMed    
    Abstract available

  59. TAO X, Zhang H, Wang L, Pan Q, et al
    Atypical squamous cells of undetermined significance cervical cytology in the Chinese population: Age-stratified reporting rates, high-risk HPV testing, and immediate histologic correlation results.
    Cancer Cytopathol. 2021;129:24-32.
    PubMed    
    Abstract available

  60. LI X, Guo M, Hou B, Zheng B, et al
    CRISPR/Cas9 nanoeditor of double knockout large fragments of E6 and E7 oncogenes for reversing drugs resistance in cervical cancer.
    J Nanobiotechnology. 2021;19:231.
    PubMed    
    Abstract available

  61. NEIBART SS, Smith TA, Fang JH, Anderson T, et al
    Assessment of Cervical Cancer Prevention and Treatment Infrastructure in Belize.
    JCO Glob Oncol. 2021;7:1251-1259.
    PubMed    
    Abstract available

  62. FU J, Zhang Y, Wang M, Hu J, et al
    Inhibition of the long noncoding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
    J Gene Med. 2021 Aug 4:e3382. doi: 10.1002/jgm.3382.
    PubMed    
    Abstract available

  63. SONG H, Liu Y, Liang H, Jin X, et al
    SPINT1-AS1 Drives Cervical Cancer Progression via Repressing miR-214 Biogenesis.
    Front Cell Dev Biol. 2021;9:691140.
    PubMed    
    Abstract available

  64. JEONG SY, Chung JY, Byeon SJ, Kim CJ, et al
    Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry.
    Front Oncol. 2021;11:665595.
    PubMed    
    Abstract available

  65. ZENG L, Chen C, Yao C
    Histone Deacetylation Regulated by KDM1A to Suppress DACT1 in Proliferation and Migration of Cervical Cancer.
    Anal Cell Pathol (Amst). 2021;2021:5555452.
    PubMed    
    Abstract available

  66. ZOU M, Zhang Q
    miR-17-5p accelerates cervical cancer cells migration and invasion via the TIMP2/MMPs signaling cascade.
    Cytotechnology. 2021;73:619-627.
    PubMed    
    Abstract available

  67. ZHANG W, Han D
    miR-185-3p targets Annexin-A8 to inhibit proliferation in cervical cancer cells.
    Cytotechnology. 2021;73:585-592.
    PubMed    
    Abstract available

  68. YAN J, Zhu J, Chen K, Yu L, et al
    Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Radiat Oncol. 2021;16:144.
    PubMed    
    Abstract available

  69. MILLER KM, Filippova OT, Hayes SA, Abu-Rustum NR, et al
    Pattern of disease and response to pembrolizumab in recurrent cervical cancer.
    Gynecol Oncol Rep. 2021;37:100831.
    PubMed    
    Abstract available

  70. LITWIN C, Smith L, Donken R, Krajden M, et al
    High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00868.
    PubMed    
    Abstract available

  71. KIM RY, Marcrom SR, Shen S
    Selection of brachytherapy applicators based on tumor size and shape for cervical cancer: simulation analysis of pear-shaped isodose dimensions.
    Med Dosim. 2021 Jul 31. pii: S0958-3947(21)00055.
    PubMed    
    Abstract available

  72. LYU H, Ren HY, Zhou SL, Zhu XL, et al
    [Mesonephric-like carcinomas of the uterine corpus with pelvic metastasis: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:961-963.
    PubMed    


  73. DUAN R, Zhao X, Zhang H, Xu X, et al
    Performance of cervical cancer screening and triage strategies among women living with HIV in China.
    Cancer Med. 2021 Aug 2. doi: 10.1002/cam4.4152.
    PubMed    
    Abstract available

  74. CHEN M, Liang X, Liang Z, Zhao L, et al
    Study on the effect and mechanism of NFKBIA on cervical cancer progress in vitro and in vivo.
    J Obstet Gynaecol Res. 2021 Aug 2. doi: 10.1111/jog.14947.
    PubMed    
    Abstract available

  75. ONAL C, Yavas G, Yavas C
    Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtisek et al.
    Strahlenther Onkol. 2021 Aug 2. pii: 10.1007/s00066-021-01819.
    PubMed    


  76. ABU-RUSTUM NR
    Reducing Disparities in Cervical Cancer Mortality Among Young Black Women.
    J Natl Compr Canc Netw. 2021;19:879-880.
    PubMed    


  77. WANG Y, Zhang L, Wang B, Cheng Y, et al
    Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Biomed Res Int. 2021;2021:6699131.
    PubMed    
    Abstract available

  78. WANG C, Zhang T, Wang K, Zhang S, et al
    ER-alpha36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2.
    Front Oncol. 2021;11:712849.
    PubMed    
    Abstract available

  79. ZHOU P, Li X, Zhou H, Fu X, et al
    Support Vector Machine Model Predicts Dose for Organs at Risk in High-Dose Rate Brachytherapy of Cervical Cancer.
    Front Oncol. 2021;11:619384.
    PubMed    
    Abstract available

  80. LI X, Zhou X, Zeng M, Zhou Y, et al
    Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer.
    J Cancer. 2021;12:5136-5143.
    PubMed    
    Abstract available

  81. XIA M, Duan LJ, Lu BN, Pang YZ, et al
    LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells.
    Chin Med J (Engl). 2021 Jul 29. pii: 00029330-900000000-98494.
    PubMed    
    Abstract available

  82. YAMANAKA Z, Sasaki T, Yamanaka A, Kato K, et al
    Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
    Cancer Biomark. 2021 Jul 23. pii: CBM201021. doi: 10.3233/CBM-201021.
    PubMed    
    Abstract available

  83. ZHANG L, Zhu A, Sun J
    Analysis of the value of MRI dynamic contrast-enhanced imaging in evaluating the prognosis of locally advanced cervical cancer after radiotherapy and chemotherapy.
    Minerva Med. 2021 Aug 2. pii: S0026-4806.21.07615.
    PubMed    


  84. TURAN T, Kimyon Comert G, Boyraz G, Kilic F, et al
    What is the impact of corpus uterine invasion on oncologic outcomes in surgically treated cervical cancer?
    J Obstet Gynaecol Res. 2021 Aug 1. doi: 10.1111/jog.14953.
    PubMed    
    Abstract available

  85. PIROVANO A, Almeida LG, Ladjal S, Bloch I, et al
    Computer-aided diagnosis tool for cervical cancer screening with weakly supervised localization and detection of abnormalities using adaptable and explainable classifier.
    Med Image Anal. 2021;73:102167.
    PubMed    
    Abstract available

  86. PAN B, Yin S, Peng F, Liu C, et al
    Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway.
    Eur J Pharmacol. 2021;908:174399.
    PubMed    
    Abstract available

  87. ZHU L, Chen J, Yan T, Gulinigaer A, et al
    Near-infrared emissive polymer coated IR-820 nanoparticles assisted photo-thermal therapy for cervical cancer cells.
    J Biophotonics. 2021 Jul 31:e202100117. doi: 10.1002/jbio.202100117.
    PubMed    
    Abstract available

  88. JEUDIN P, Abebe T, Butler R, Hooi D, et al
    Human Papilloma Virus Distribution Across the African Diaspora.
    JCO Glob Oncol. 2021;7:1206-1208.
    PubMed    
    Abstract available

  89. SHARMA A, Alatise OI, O'Connell K, Ogunleye SG, et al
    Healthcare utilisation, cancer screening and potential barriers to accessing cancer care in rural South West Nigeria: a cross-sectional study.
    BMJ Open. 2021;11:e040352.
    PubMed    
    Abstract available

  90. PORTNOY A, Pedersen K, Trogstad L, Hansen BT, et al
    Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.
    Prev Med. 2021;150:106688.
    PubMed    


  91. FISHER H, Evans K, Reynolds R, Yates J, et al
    Secondary analyses to test the impact on inequalities and uptake of the schools-based human papillomavirus (HPV) vaccination programme by stage of implementation of a new consent policy in the south-west of England.
    BMJ Open. 2021;11:e044980.
    PubMed    
    Abstract available

  92. KATANGA JJ, Rasch V, Manongi R, Pembe AB, et al
    Concordance in HPV Detection Between Self-Collected and Health Provider-Collected Cervicovaginal Samples Using careHPV in Tanzanian Women.
    JCO Glob Oncol. 2021;7:985-991.
    PubMed    
    Abstract available

  93. DODD RH, Freeman M, Dekaj F, Bamforth J, et al
    Awareness of the link between human papillomavirus and oral cancer in UK university students.
    Prev Med. 2021;150:106660.
    PubMed    
    Abstract available

  94. CLARK M, Jembere N, Kupets R
    The impact of a universal human papilloma virus (HPV) vaccination program on lower genital tract dysplasia and genital warts.
    Prev Med. 2021;150:106641.
    PubMed    
    Abstract available

  95. ISHII K, Tabuchi T, Iso H
    Combined patterns of participation in cervical, breast, and colorectal cancer screenings and factors for non-participation in each screening among women in Japan.
    Prev Med. 2021;150:106627.
    PubMed    
    Abstract available

  96. VAN GOOL K, Mu C, Hall J
    Does more investment in primary care improve health system performance?
    Health Policy. 2021;125:717-724.
    PubMed    
    Abstract available

  97. CHAI Z, Liu D, Li X, Zhao Y, et al
    A tumor-targeted near-infrared fluorescent probe for HNO and its application to the real-time monitoring of HNO release in vivo.
    Chem Commun (Camb). 2021;57:5063-5066.
    PubMed    
    Abstract available

  98. GONDHOWIARDJO S, Christina N, Ganapati NPD, Hawariy S, et al
    Five-Year Cancer Epidemiology at the National Referral Hospital: Hospital-Based Cancer Registry Data in Indonesia.
    JCO Glob Oncol. 2021;7:190-203.
    PubMed    
    Abstract available

  99. UAAMNUICHAI S, Panyakhamlerd K, Suwan A, Suwajo P, et al
    Neovaginal and Anal High-Risk Human Papillomavirus DNA Among Thai Transgender Women in Gender Health Clinics.
    Sex Transm Dis. 2021;48:547-549.
    PubMed    
    Abstract available

  100. RUFFIEUX Y, Muchengeti M, Egger M, Efthimiou O, et al
    Immunodeficiency and Cancer in 3.5 Million People Living with Human Immunodeficiency Virus: the South African HIV Cancer Match Study.
    Clin Infect Dis. 2021 Feb 2. pii: 6126767. doi: 10.1093.
    PubMed    
    Abstract available

  101. CHOU JF, Ford JS, Kleinerman RA, Abramson DH, et al
    General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study.
    Pediatr Blood Cancer. 2021;68:e28873.
    PubMed    
    Abstract available

  102. TOSTI ME, Marceca M, Eugeni E, D'Angelo F, et al
    Health assessment for migrants and asylum seekers upon arrival and while hosted in reception centres: Italian guidelines.
    Health Policy. 2021;125:393-405.
    PubMed    
    Abstract available

  103. PADASH BARMCHI M, Thomas M, Thatte JV, Vats A, et al
    Inhibition of kinase IKKbeta suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6.
    Sci Rep. 2021;11:1111.
    PubMed    
    Abstract available

  104. BUKHARI M, Deng H, Sipes D, Ruane-Foster M, et al
    KCa3.1-dependent uptake of the cytotoxic DNA-binding dye Hoechst 33258 into cancerous but not healthy cervical cells.
    J Biol Chem. 2021;296:100084.
    PubMed    
    Abstract available

  105. LIU W, Jin X, Li J, Xue Y, et al
    Study of cervical precancerous lesions detection by spectroscopy and support vector machine.
    Minim Invasive Ther Allied Technol. 2021;30:208-214.
    PubMed    
    Abstract available

  106. HUANG G, Jiang M, Wu X, Xiang X, et al
    KGFR and MMP9 expression are correlates with cancer growth in cervical carcinoma.
    Minerva Med. 2021;112:524-525.
    PubMed    


  107. TANG J, Pan H, Wang W, Qi C, et al
    MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer.
    Clin Transl Oncol. 2021 Aug 13. pii: 10.1007/s12094-021-02687.
    PubMed    
    Abstract available

  108. ZHAO R, Song J, Jin Y, Liu Y, et al
    Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
    J Mol Histol. 2021 Aug 13. pii: 10.1007/s10735-021-10007.
    PubMed    
    Abstract available

  109. WANG B, Yuan Y, Zou Y, Qi Z, et al
    Fructose-1,6-bisphosphatase 2 represses cervical cancer progression via inhibiting aerobic glycolysis through promoting pyruvate kinase isozyme type M2 ubiquitination.
    Anticancer Drugs. 2021 Aug 11. pii: 00001813-900000000-98328.
    PubMed    
    Abstract available

  110. KOUDRIAVTSEVA T, Lorenzano S, Anelli V, Sergi D, et al
    Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.
    Front Oncol. 2021;11:669753.
    PubMed    
    Abstract available

  111. FENG Y, Li X, Ma Q, Zhang S, et al
    Intercellular Adhesion Molecule-1 Gene Polymorphisms and Susceptibility to Cervical Cancer in the Northern Chinese Han Population.
    Front Genet. 2021;12:668539.
    PubMed    
    Abstract available

  112. LEE TH, Song C, Kim IA, Kim JS, et al
    Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible.
    Radiat Oncol. 2021;16:148.
    PubMed    
    Abstract available

  113. BRAU-FIGUEROA H, Arango-Bravo E, Castro-Eguiluz D, Galicia-Carmona T, et al
    Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities.
    Cancer Res Treat. 2021 Aug 10. pii: crt.2021.375. doi: 10.4143/crt.2021.
    PubMed    
    Abstract available

  114. XIAO M, Ma X, Ma F, Li Y, et al
    Whole-tumor histogram analysis of apparent diffusion coefficient for differentiating adenosquamous carcinoma and adenocarcinoma from squamous cell carcinoma in patients with cervical cancer.
    Acta Radiol. 2021 Aug 12:2841851211035915. doi: 10.1177/02841851211035915.
    PubMed    
    Abstract available

  115. GAN YX, Du QH, Li J, Wei YP, et al
    Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer.
    Front Oncol. 2021;11:690777.
    PubMed    
    Abstract available

  116. RAHATGAONKAR VG, Deshpande AA, Oka GA
    Screening for cervical cancer in HIV-infected women: A review of literature.
    Indian J Cancer. 2021 Aug 7. pii: 323440. doi: 10.4103.
    PubMed    
    Abstract available

  117. GUO H, Wen Z, Yang S, Qi H, et al
    Association of p73 G4C14-A4T14 and p53 codon 72 polymorphism with cervical cancer in Chinese population.
    Indian J Cancer. 2021 Jul 2. pii: 320441. doi: 10.4103.
    PubMed    
    Abstract available

  118. BUDUKH A, Maheshwari A, Bagal S, Singh A, et al
    Factors influencing women to participate in cervical cancer screening by providing menstrual pads: A population-based study from rural areas of Maharashtra state, India.
    Indian J Cancer. 2021 Jun 21. pii: 318903. doi: 10.4103.
    PubMed    
    Abstract available

  119. VISWANATHAN V, Ganeshkumar P, Selvam JM, Selvavinayagam TS, et al
    Referral mechanism and beneficiary adherence in cervical cancer screening program in Tiruchirappalli district, Tamil Nadu state, India, 2012-2015.
    Indian J Cancer. 2021 Jun 21. pii: 318900. doi: 10.4103.
    PubMed    
    Abstract available

  120. KRISHNAMOORTHY Y, Rajaa S, Giriyappa DK
    Global pattern and trend of cervical cancer incidence from 1993 to 2012: Joinpoint regression and age-period-cohort analysis.
    Indian J Cancer. 2021 May 14. pii: 316111. doi: 10.4103/ijc.IJC_1043.
    PubMed    
    Abstract available

  121. WANG Y, Ouyang Y, Su J, Bai Z, et al
    Role of locoregional surgery in treating FIGO 2009 stage IVB cervical cancer patients: a population-based study.
    BMJ Open. 2021;11:e042364.
    PubMed    
    Abstract available

  122. JENNIFER LG, Emmanuel K, Justine L, Delphine L, et al
    Morbidity following image-guided brachytherapy for cervical cancer: Patient and treatment related factors.
    Brachytherapy. 2021 Aug 8. pii: S1538-4721(21)00110.
    PubMed    
    Abstract available

  123. OBOL JH, Lin S, Obwolo MJ, Harrison R, et al
    Provision of cervical cancer prevention services in Northern Uganda: a survey of health workers from rural health centres.
    BMC Health Serv Res. 2021;21:794.
    PubMed    
    Abstract available

  124. BUI CN, Hong S, Suh M, Jun JK, et al
    Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program.
    J Gynecol Oncol. 2021;32:e81.
    PubMed    
    Abstract available

  125. ONAL C, Guler OC, Reyhan M, Yapar AF, et al
    Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy.
    J Gynecol Oncol. 2021;32:e74.
    PubMed    
    Abstract available

  126. SCHMID BC, Yuan R, Watterson L, Yu J, et al
    Two case studies of cardiac arrest occurring in medically fit patients undergoing radical hysterectomy for cervical cancer.
    Gynecol Oncol Rep. 2021;37:100823.
    PubMed    
    Abstract available

  127. LIU M, Guo J, Sun H, Liu G, et al
    The effect of psychological nursing on the short- and long-term negative emotions and quality of life of cervical cancer patients undergoing postoperative chemotherapy.
    Am J Transl Res. 2021;13:7952-7959.
    PubMed    
    Abstract available

  128. LU H, Wu Y, Liu X, Huang H, et al
    The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.
    Cancer Manag Res. 2021;13:6065-6078.
    PubMed    
    Abstract available

  129. ZHENG J, Huang J, Ma W, Yang W, et al
    The Antitumor Activity of CAR-T-PD1 Cells Enhanced by HPV16mE7-Pulsed and SOCS1-Silenced DCs in Cervical Cancer Models.
    Cancer Manag Res. 2021;13:6045-6053.
    PubMed    
    Abstract available

  130. ALFARO K, Maza M, Cremer M, Masch R, et al
    Removing global barriers to cervical cancer prevention and moving towards elimination.
    Nat Rev Cancer. 2021 Aug 10. pii: 10.1038/s41568-021-00396.
    PubMed    


  131. WANG S, Wen H, Gao Y, Lv Q, et al
    Assessment of Pelvic Floor Function and Quality of Life in Patients Treated for Cervical Cancer: A Multicenter Retrospective Study.
    Gynecol Obstet Invest. 2021 Aug 10:1-8. doi: 10.1159/000517995.
    PubMed    
    Abstract available

  132. LORENZI NPC, Termini L, Ferreira-Filho ES, Nunes RAL, et al
    A positive HPV test with positive p16/Ki-67 double staining in self-sampled vaginal material is an accurate tool to detect women at risk for cervical cancer.
    Cancer Cytopathol. 2021 Aug 10. doi: 10.1002/cncy.22498.
    PubMed    
    Abstract available

  133. KUNNUMMAL M, Angelin M, Das AV
    PIWI proteins and piRNAs in cervical cancer: a propitious dart in cancer stem cell-targeted therapy.
    Hum Cell. 2021 Aug 9. pii: 10.1007/s13577-021-00590.
    PubMed    
    Abstract available

  134. PARK YR, Kim YJ, Ju W, Nam K, et al
    Comparison of machine and deep learning for the classification of cervical cancer based on cervicography images.
    Sci Rep. 2021;11:16143.
    PubMed    
    Abstract available

  135. LI J, Gong X, Li P, Xiao L, et al
    Application of Da Vinci robotic surgery system in cervical cancer: A single institution experience of 557 cases.
    Asian J Surg. 2021 Aug 6. pii: S1015-9584(21)00468.
    PubMed    
    Abstract available

  136. WASSIE M, Fentie B, Asefa T
    Human immune deficiency virus among cervical cancer patients at Tikur Anbessa Specialized Hospital, Ethiopia: a cross sectional study.
    BMC Womens Health. 2021;21:294.
    PubMed    
    Abstract available

  137. RUTTANAPATTANAKUL J, Wikan N, Chinda K, Jearanaikulvanich T, et al
    Essential Oil from Zingiber ottensii Induces Human Cervical Cancer Cell Apoptosis and Inhibits MAPK and PI3K/AKT Signaling Cascades.
    Plants (Basel). 2021;10.
    PubMed    
    Abstract available

  138. SALCICCIOLI I, Zhou CD, Okonji EC, Shalhoub J, et al
    European trends in cervical cancer mortality in relation to national screening programs, 1985-2014.
    Cancer Epidemiol. 2021;74:102002.
    PubMed    
    Abstract available

  139. BELGHITI J, Favier A, Uzan C, Motton S, et al
    Robotic Radical Trachelectomy with Primary Vaginal Closure to Spare Fertility in Young Patients with Early-Stage Cervical Cancer.
    Ann Surg Oncol. 2021 Aug 9. pii: 10.1245/s10434-021-10550.
    PubMed    
    Abstract available

  140. XU AL, Wang WS, Zhao MY, Sun JN, et al
    Circular RNA circ_0011385 promotes cervical cancer progression through competitively binding to miR-149-5p and up-regulating SOX4 expression.
    Kaohsiung J Med Sci. 2021 Aug 9. doi: 10.1002/kjm2.12432.
    PubMed    
    Abstract available

  141. SIEGLER E, Goldberg Y, Siegler Y, Shaked-Mishan P, et al
    The Association Between Clearance of Human Papillomavirus After Conization for Cervical Cancer and Absence of Cancer.
    J Low Genit Tract Dis. 2021 Aug 5. pii: 00128360-900000000-99330.
    PubMed    
    Abstract available

  142. HE Y, Chen W, Guo Z, Yi D, et al
    The performance of Cobas HPV test for cervical cancer screening in Chinese female migrant workers.
    Epidemiol Infect. 2021 Aug 9:1-29. doi: 10.1017/S0950268821001904.
    PubMed    


  143. MENG L, Zhang Q, Han Q, Sun X, et al
    Embryonic cervical rhabdomyosarcoma complicated with uterine inversion with cerebral venous sinus thrombosis as the first symptom: a case report and literature review.
    J Int Med Res. 2021;49:3000605211031776.
    PubMed    
    Abstract available

  144. ADEEL MM, Jiang H, Arega Y, Cao K, et al
    Structural Variations of the 3D Genome Architecture in Cervical Cancer Development.
    Front Cell Dev Biol. 2021;9:706375.
    PubMed    
    Abstract available

  145. CHEN J, Wu Z, Liu Y, Wang L, et al
    Prevalence, Association Relation, and Dynamic Evolution Analysis of Critical Values in Health Checkup in China: A Retrospective Study.
    Front Public Health. 2021;9:630356.
    PubMed    
    Abstract available

  146. MENDONCA CARNEIRO M
    Cervical cancer elimination: rising up to the challenge.
    Women Health. 2021;61:617-618.
    PubMed    


  147. MARTIN-TOVAR EA, Badillo-Alvarado AH, Cocom-Poot LE
    Dosimetric study of a hybrid plan technique for external beam radiotherapy in patients with cervical cancer.
    Radiat Environ Biophys. 2021 Aug 6. pii: 10.1007/s00411-021-00931.
    PubMed    
    Abstract available

  148. FREIJOMIL-VAZQUEZ C, Gastaldo D, Coronado C, Movilla-Fernandez MJ, et al
    Asymmetric Power Relations in Gynaecological Consultations for Cervical Cancer Prevention: Biomedical and Gender Issues.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  149. KIM SI, Lee S, Choi CH, Lee M, et al
    Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  150. PARK J, Kim YJ, Song MK, Nam JH, et al
    Definitive Chemoradiotherapy versus Radical Hysterectomy Followed by Tailored Adjuvant Therapy in Women with Early-Stage Cervical Cancer Presenting with Pelvic Lymph Node Metastasis on Pretreatment Evaluation: A Propensity Score Matching Analysis.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  151. HAN L, Wang Q, Zhao L, Feng X, et al
    A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  152. CAMARA H, Zhang Y, Lafferty L, Vallely AJ, et al
    Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis.
    BMC Public Health. 2021;21:1503.
    PubMed    
    Abstract available

  153. MADHIVANAN P, Krupp K, Coudray M, Colbert B, et al
    Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.
    Vaccine. 2021 Jul 19. pii: S0264-410X(21)00903.
    PubMed    
    Abstract available

  154. SIDHU H, Capalash N
    Synergistic anti-cancer action of salicylic acid and cisplatin on HeLa cells elucidated by network pharmacology and in vitro analysis.
    Life Sci. 2021;282:119802.
    PubMed    
    Abstract available

  155. SONG S, Kucik JE
    Trends in the Utilization of Recommended Clinical Preventive Services, 2011-2019.
    Am J Prev Med. 2021;61:149-157.
    PubMed    
    Abstract available

  156. CHEN L, Dong Y, Li J, Zhao J, et al
    The genomic distribution map of human papillomavirus in Western China.
    Epidemiol Infect. 2021;149:e135.
    PubMed    
    Abstract available

  157. SAMSONOVA A, El Hage K, Desforges B, Joshi V, et al
    Lin28, a major translation reprogramming factor, gains access to YB-1-packaged mRNA through its cold-shock domain.
    Commun Biol. 2021;4:359.
    PubMed    
    Abstract available

  158. TAKU O, Mbulawa ZZA, Phohlo K, Garcia-Jardon M, et al
    Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  159. ZORZATO P, Zambon M, Gori S, Frayle H, et al
    Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  160. QI L, Pan T, Ou L, Ye Z, et al
    Biocompatible nucleus-targeted graphene quantum dots for selective killing of cancer cells via DNA damage.
    Commun Biol. 2021;4:214.
    PubMed    
    Abstract available

  161. ALIMENA S, Manning-Geist B, Pena N, Vitonis AF, et al
    Outcomes by Race Among Women Referred to an Academic Colposcopy Clinic with a Patient Navigation Program.
    J Womens Health (Larchmt). 2021;30:902-909.
    PubMed    
    Abstract available

  162. MOURYA A, Mohan Aggarwal L, Choudhary S
    Letter to the editor on the research article "Total reference air kerma can accurately predict isodose surface volumes in cervix cancer brachytherapy. A multicenter study".
    Brachytherapy. 2021;20:290.
    PubMed    


  163. VINK FJ, Lissenberg-Witte BI, Meijer CJLM, Berkhof J, et al
    FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
    Clin Microbiol Infect. 2021;27:125.
    PubMed    
    Abstract available

  164. PANDEY N, Chauhan A, Raithatha N, Patel P, et al
    Influence of TLR4 and TLR9 polymorphisms and haplotypes on multiple hrHPV infections and HPV16 copy number in cervical cancer and cervicitis.
    Microb Pathog. 2021 Aug 17:105149. doi: 10.1016/j.micpath.2021.105149.
    PubMed    
    Abstract available

  165. PERKINS RB, Adcock R, Benard V, Cuzick J, et al
    Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations.
    Prev Med. 2021 Aug 17:106770. doi: 10.1016/j.ypmed.2021.106770.
    PubMed    
    Abstract available

  166. DAYYANI M, Hoseinian-Azghadi E, Miri-Hakimabad H, Rafat-Motavalli L, et al
    Radiobiological comparison between (60) Co and (192) Ir high-dose-rate brachytherapy sources: Part I - cervical cancer.
    Med Phys. 2021 Aug 20. doi: 10.1002/mp.15177.
    PubMed    
    Abstract available

  167. FENG Y, Wang Z, Yang N, Liu S, et al
    Identification of Biomarkers for Cervical Cancer Radiotherapy Resistance Based on RNA Sequencing Data.
    Front Cell Dev Biol. 2021;9:724172.
    PubMed    
    Abstract available

  168. IND T
    Fertility sparing treatment for cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2021;75:1.
    PubMed    


  169. ZHAO M, Luo L, Zhang CH, Zhang JP, et al
    Healthy-related quality of life in patients with cervical cancer in Southwest China: a cross-sectional study.
    BMC Health Serv Res. 2021;21:841.
    PubMed    
    Abstract available

  170. SAUVAGEAU C, Gilca V, Ouakki M, Kiely M, et al
    Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women.
    Hum Vaccin Immunother. 2021 Aug 19:1-4. doi: 10.1080/21645515.2021.1961470.
    PubMed    
    Abstract available

  171. O'MALLEY DM, Randall LM, Jackson CG, Coleman RL, et al
    RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer.
    Future Oncol. 2021 Aug 19. doi: 10.2217/fon-2021-0529.
    PubMed    
    Abstract available

  172. YOSHIDA K, Kondo E, Matsumoto T, Maki S, et al
    Laparoscopic retroperitoneal para-aortic lymph node biopsy in advanced cervical cancer with pelvic lymph node metastases: A single-center prospective study.
    J Obstet Gynaecol Res. 2021 Aug 18. doi: 10.1111/jog.14990.
    PubMed    
    Abstract available

  173. BODDU A, Bhatla N, Vashist S, Mathur S, et al
    Cervical Cancer Screening in HIV-Positive Women in India: Why, When and How?
    J Obstet Gynaecol India. 2021;71:304-312.
    PubMed    
    Abstract available

  174. JAYATILAKEBANDA I, Tsang YM, Hoskin P
    Correction to: High dose simultaneous integrated boost for node positive cervical cancer.
    Radiat Oncol. 2021;16:156.
    PubMed    


  175. PIETERS MM, Proeschold-Bell RJ, Coffey E, Huchko MJ, et al
    Knowledge, attitudes, and practices regarding cervical cancer screening among women in metropolitan Lima, Peru: a cross-sectional study.
    BMC Womens Health. 2021;21:304.
    PubMed    
    Abstract available

  176. QI Z, Ding L, Meng D, Liu H, et al
    [Relationship between serum folate and CIN1 prognosis and its interaction with HR-HPV infection].
    Zhonghua Zhong Liu Za Zhi. 2021;43:866-871.
    PubMed    
    Abstract available

  177. ROBERSON ML, McGee-Avila JK
    Justice-Involved Women and Cervical Cancer Disparities: Issues of Surveillance, Education, and Policy.
    J Correct Health Care. 2021 Aug 18. doi: 10.1089/jchc.19.09.0073.
    PubMed    
    Abstract available

  178. MATSUMOTO YK, Kido A, Moribata Y, Chigusa Y, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging for International Federation of Gynecology and Obstetrics 2018 IB to IIB Cervical Cancer Staging: Comparison Among Magnetic Resonance Sequences and Pathologies.
    J Comput Assist Tomogr. 2021 Aug 16. pii: 00004728-900000000-98882.
    PubMed    
    Abstract available

  179. YANG W, Wang X, Song S, Chu Y, et al
    Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171.
    Anticancer Drugs. 2021 Aug 16. pii: 00001813-900000000-98321.
    PubMed    
    Abstract available

  180. FENG L, Zhao M, Wu A
    CircASAP1 promotes the development of cervical cancer through sponging miR-338-3p to upregulate RPP25.
    Anticancer Drugs. 2021 Aug 16. pii: 00001813-900000000-98312.
    PubMed    
    Abstract available

  181. LI Z, Chen C, Liu P, Lu A, et al
    Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.
    Arch Gynecol Obstet. 2021 Aug 18. pii: 10.1007/s00404-021-06185.
    PubMed    
    Abstract available

  182. FAGUNDES TP, Albuquerque RM, Miranda DLP, Landeiro LCG, et al
    Dealing with cancer screening in the COVID-19 era.
    Rev Assoc Med Bras (1992). 2021;67Suppl 1.
    PubMed    
    Abstract available

  183. WANG Z, Xiao R, Huang J, Qin X, et al
    The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer.
    Microb Ecol. 2021 Aug 17. pii: 10.1007/s00248-021-01800.
    PubMed    
    Abstract available

  184. HERNANDEZ-AGUADO JJ, de La Fuente-Valero J, Ramirez Mena M, Ortega-Medina L, et al
    Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study.
    Enferm Infecc Microbiol Clin. 2021 Aug 14. pii: S0213-005X(21)00231.
    PubMed    
    Abstract available

  185. ZOU H, Chen H, Liu S, Gan X, et al
    Identification of a novel circ_0018289/miR-183-5p/TMED5 regulatory network in cervical cancer development.
    World J Surg Oncol. 2021;19:246.
    PubMed    
    Abstract available

  186. HU SY, Zhao XL, Zhang Y, Qiao YL, et al
    [Interpretation of"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition"].
    Zhonghua Yi Xue Za Zhi. 2021;101:1-5.
    PubMed    
    Abstract available

  187. AKASAKA M, Yoshida K, Maezawa T, Kondo E, et al
    [Observation of Child Development in a Uterine Cervical Cancer Patient Who Received Chemotherapy during Pregnancy].
    Gan To Kagaku Ryoho. 2021;48:1069-1071.
    PubMed    
    Abstract available

  188. CAO L, Yang J, Rong Z, Li L, et al
    A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening.
    Med Image Anal. 2021;73:102197.
    PubMed    
    Abstract available

  189. FARR MA, Joshi TP, Lewis DJ
    Trends in cervical cancer screening from 2007 to 2016: association with decreased genital melanoma detection in females.
    Int J Dermatol. 2021 Aug 17. doi: 10.1111/ijd.15859.
    PubMed    


  190. KANO Y, Ikushima H, Sasaki M, Haga A, et al
    Automatic contour segmentation of cervical cancer using artificial intelligence.
    J Radiat Res. 2021 Aug 14. pii: 6352525. doi: 10.1093.
    PubMed    
    Abstract available

  191. SABALIAUSKAS V, Tiskevicius S
    Diagnosing sacral insufficiency fractures after radiotherapy in women with cervical cancer: Report of three cases.
    Radiol Case Rep. 2021;16:2938-2944.
    PubMed    
    Abstract available

  192. HUANG X, Shi H, Shi X, Jiang X, et al
    LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p.
    J Biol Res (Thessalon). 2021;28:20.
    PubMed    
    Abstract available

  193. MATIJEVIC M, Zakula J, Koricanac L, Radoicic M, et al
    Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles.
    Photochem Photobiol Sci. 2021 Aug 16. pii: 10.1007/s43630-021-00082.
    PubMed    
    Abstract available

  194. HUANG H, Quan Y, Qi X, Liu P, et al
    Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: A case series and literature review.
    Medicine (Baltimore). 2021;100:e26845.
    PubMed    
    Abstract available

  195. NKWONTA CA, Hilfinger Messias DK, Felder T, Luchok K, et al
    Intervention to Reduce Stigma and Improve Knowledge of HPV and Cervical Cancer in Nigeria: A Community-Based Assessment.
    Fam Community Health. 2021;44:245-256.
    PubMed    
    Abstract available

  196. JOSEPH AN, Bhatla N
    Population-based human papillomavirus testing: The new paradigm for cervical cancer screening.
    Natl Med J India. 2021;34:36-37.
    PubMed    


  197. CHAWLA B, Taneja N, Awasthi AA, Kaur KN, et al
    Knowledge, attitude, and practice on screening toward cervical cancer among health professionals in India-A review.
    Womens Health (Lond). 2021;17:17455065211017066.
    PubMed    
    Abstract available

  198. SAMPSON CN, Nkpeebo SD, Degley TA
    Knowledge, attitude and health beliefs on cervical cancer screening in Ajumako-Eyan-Essiam District, Ghana.
    Can Oncol Nurs J. 2021;31:285-290.
    PubMed    
    Abstract available

  199. NIYONSENGA G, Gishoma D, Sego R, Uwayezu MG, et al
    Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali - Rwanda.
    Can Oncol Nurs J. 2021;31:266-274.
    PubMed    
    Abstract available

  200. LIU L, Wang M, Li X, Yin S, et al
    An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies.
    Front Med (Lausanne). 2021;8:682366.
    PubMed    
    Abstract available

  201. ZHANG Y, Hu Y, Zhao S, Cui C, et al
    The Utility of PET/CT Metabolic Parameters Measured Based on Fixed Percentage Threshold of SUVmax and Adaptive Iterative Algorithm in the New Revised FIGO Staging System for Stage III Cervical Cancer.
    Front Med (Lausanne). 2021;8:680072.
    PubMed    
    Abstract available

  202. WANG Q, Cao Z, Wei Y, Zhang J, et al
    Potential Role of SWI/SNF Complex Subunit Actin-Like Protein 6A in Cervical Cancer.
    Front Oncol. 2021;11:724832.
    PubMed    
    Abstract available

  203. WAN T, Tu H, Liu L, Huang H, et al
    Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study.
    Dis Markers. 2021;2021:1375123.
    PubMed    
    Abstract available

  204. CERINA D, Matkovic V, Katic K, Belac Lovasic I, et al
    Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients.
    J Oncol. 2021;2021:2815623.
    PubMed    
    Abstract available

  205. SHOAIB S, Tufail S, Sherwani MA, Yusuf N, et al
    Phenethyl Isothiocyanate Induces Apoptosis Through ROS Generation and Caspase-3 Activation in Cervical Cancer Cells.
    Front Pharmacol. 2021;12:673103.
    PubMed    
    Abstract available

  206. SHEN L, Gwak SR, Cui ZY, Joo JC, et al
    Astragalus-Containing Chinese Herbal Medicine Combined With Chemotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis.
    Front Pharmacol. 2021;12:587021.
    PubMed    
    Abstract available

  207. KALLIS K, Mayadev J, Kisling K, Brown D, et al
    Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer.
    Brachytherapy. 2021 Aug 12. pii: S1538-4721(21)00450.
    PubMed    
    Abstract available

  208. LEE SW, Hong JH, Yu M, Jeong S, et al
    Serum conversion pattern of SCC-Ag levels between pre- and post-chemoradiotherapy predicts recurrence and metastasis in cervical cancer: a multi-institutional analysis.
    Clin Exp Metastasis. 2021 Aug 14. pii: 10.1007/s10585-021-10115.
    PubMed    
    Abstract available

  209. JI F, Lu Y, Chen S, Yu Y, et al
    IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m(6)A/FOXM1 manner.
    Cell Death Discov. 2021;7:215.
    PubMed    
    Abstract available

  210. HUANG SH, Peng S, Wang QY, Hu QH, et al
    Gold nanorods conjugated with biocompatible zwitterionic polypeptide for combined chemo-photothermal therapy of cervical cancer.
    Colloids Surf B Biointerfaces. 2021;207:112014.
    PubMed    
    Abstract available

  211. YANG N, Liu P, Cai C, Zhang R, et al
    Triple signal amplification strategy for the ultrasensitive electrochemical detection of human papillomavirus 16 E6/E7 mRNA.
    Enzyme Microb Technol. 2021;149:109855.
    PubMed    
    Abstract available

  212. KARNAK I, Ceylan AC, Haliloglu M, Ozon A, et al
    Sertoli-Leydig cell tumor, thyroid follicular carcinoma and rhabdomyosarcoma of the uterine cervix in a prepubertal girl with pathogenic germline variant in DICER1 gene.
    Turk J Pediatr. 2021;63:500-505.
    PubMed    
    Abstract available

  213. ARANDA E, Franck JE, Ringa V, Sassenou J, et al
    Social inequalities in participation in cancer screening: does the mode of data collection matter? The CONSTANCES cohort.
    Eur J Public Health. 2021;31:602-608.
    PubMed    
    Abstract available

  214. GONG H, Wang P, Yu M, Zhu Y, et al
    The Role of the Hematopoietic Cell-Specific Protein 1-Associated Protein X-1 in Human Papillomavirus 16 E2-Induced Human Cervical Squamous Carcinoma Cell Apoptosis via a Mitochondria-Dependent Pathway.
    Gynecol Obstet Invest. 2021;86:273-282.
    PubMed    
    Abstract available

  215. ZENA D, Elfu B, Mulatu K
    Prevalence and Associated Factors of Precancerous Cervical Lesions among Women in Ethiopia: A Systematic Review and Meta-Analysis.
    Ethiop J Health Sci. 2021;31:189-200.
    PubMed    
    Abstract available

  216. ARREDONDO-GALVEZ CG, Acuna-Gonzalez D, Cantu-de-Leon D, Chanona-Vilchis JG, et al
    Association of p16 and Ki-67 with Risk of Recurrence in Previously Treated Cervical High-Grade Squamous Intraepithelial Lesions.
    Gynecol Obstet Invest. 2021;86:293-298.
    PubMed    
    Abstract available

  217. MUNOZ-QUILES C, Diez-Domingo J, Acedo L, Sanchez-Alonso V, et al
    On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model.
    Viruses. 2021;13.
    PubMed    
    Abstract available

  218. LIN W, Chen B, Hu H, Yuan S, et al
    Joint effects of HPV-related knowledge and socio-demographic factors on HPV testing behaviour among females in Shenzhen.
    Eur J Public Health. 2021;31:582-588.
    PubMed    
    Abstract available

  219. SLONINA D, Kabat D, Biesaga B, Janecka-Widla A, et al
    Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer.
    DNA Repair (Amst). 2021;103:103113.
    PubMed    
    Abstract available

  220. COUSELO-RODRIGUEZ C, Perez-Feal P, Alarcon-Perez CE, Bou-Boluda L, et al
    Clearance of genital warts in a pediatric patient following administration of the nonavalent human papillomavirus vaccine.
    Int J Dermatol. 2021;60:e377-e379.
    PubMed    


  221. TEWARI P, Banka P, Kernan N, Reynolds S, et al
    Prevalence and concordance of oral HPV infections with cervical HPV infections in women referred to colposcopy with abnormal cytology.
    J Oral Pathol Med. 2021;50:692-699.
    PubMed    
    Abstract available

  222. GUO XM, Tom L, Leung I, O'Brian C, et al
    Associations between Fatalistic Cancer Beliefs and Cancer-Screening Behaviors in Chinese American Immigrant Women.
    J Immigr Minor Health. 2021;23:699-706.
    PubMed    
    Abstract available

  223. ARITA A, Takahashi H, Uemura M, Mizushima T, et al
    Laparoscopic para-aortic lymphadenectomy after multiple previous abdominal surgeries - a video vignette.
    Colorectal Dis. 2021;23:1019-1020.
    PubMed    


  224. SRISUTTAYASATHIEN M, Manchana T
    Adherence to follow-up in women with cervical intraepithelial neoplasia grade 1.
    Taiwan J Obstet Gynecol. 2021;60:56-59.
    PubMed    
    Abstract available

  225. CUDJOE J, Nkimbeng M, Turkson-Ocran RA, Commodore-Mensah Y, et al
    Understanding the Pap Testing Behaviors of African Immigrant Women in Developed Countries: A Systematic Review.
    J Immigr Minor Health. 2021;23:840-856.
    PubMed    
    Abstract available

  226. ST-MARTIN G, Thamsborg LH, Andersen B, Christensen J, et al
    Management of low-grade cervical cytology in young women. Cohort study from Denmark.
    Acta Oncol. 2021;60:444-451.
    PubMed    
    Abstract available

  227. IIJIMA K, Murakami N, Nakamura S, Nishioka S, et al
    Configuration analysis of the injection position and shape of the gel spacer in gynecologic brachytherapy.
    Brachytherapy. 2021;20:95-103.
    PubMed    
    Abstract available

  228. MBOUMBA BOUASSA RS, Gubavu C, Veyer D, Robin L, et al
    High Prevalence of Cervical High-Risk Human Papillomavirus Harboring Atypical Genotypes in Human Immunodeficiency Virus -Infected and -Uninfected First-Generation Adult Immigrant Women Originating from Sub-Saharan Africa and Living in France.
    J Immigr Minor Health. 2021;23:308-319.
    PubMed    
    Abstract available

  229. MOURYA A, Choudhary S, Shahi UP, Sharma N, et al
    A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma.
    Brachytherapy. 2021;20:118-127.
    PubMed    
    Abstract available

  230. YENIGUL NN, Yazici Yilmaz F, Ayhan I
    Can Serum Vitamin B12 and Folate Levels Predict HPV Penetration in Patients with ASCUS?
    Nutr Cancer. 2021;73:602-608.
    PubMed    
    Abstract available

  231. ZHANG XT, Hu J, Su LH, Geng CA, et al
    Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift.
    Phytomedicine. 2021;91:153707.
    PubMed    
    Abstract available

  232. ZHANG J, Song H, Chen C, Chen L, et al
    'Methyltransferase-like protein 11A promotes migration of cervical cancer cells via up-regulating ELK3.
    Pharmacol Res. 2021 Aug 24:105814. doi: 10.1016/j.phrs.2021.105814.
    PubMed    
    Abstract available

  233. HERTZUM-LARSEN R, Kjaer SK, Frederiksen K, Thomsen LT, et al
    Follow-up after abnormal cervical cancer screening in immigrants compared with Danish-born women - A nationwide register study.
    Prev Med. 2021 Aug 24:106776. doi: 10.1016/j.ypmed.2021.106776.
    PubMed    
    Abstract available

  234. JAJODIA A, Gupta A, Prosch H, Mayerhoefer M, et al
    Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for Clinical Outcome Prognostication in Cervical Cancer.
    Tomography. 2021;7:344-357.
    PubMed    
    Abstract available

  235. ZHOU H, Li A, Li C, Wu M, et al
    The co-expression of CBX8 and PD-L1 and prognostic value in cervical cancer.
    Medicine (Baltimore). 2021;100:e27056.
    PubMed    
    Abstract available

  236. WANG L, Liu S, Xu T, Yuan L, et al
    Sentinel lymph node mapping in early-stage cervical cancer: Meta-analysis.
    Medicine (Baltimore). 2021;100:e27035.
    PubMed    
    Abstract available

  237. THOMAS S, Gunasangkaran G, Arumugam VA, Muthukrishnan S, et al
    Synthesis and Characterization of Zinc Oxide Nanoparticles of Solanum nigrum and Its Anticancer Activity via the Induction of Apoptosis in Cervical Cancer.
    Biol Trace Elem Res. 2021 Aug 27. pii: 10.1007/s12011-021-02898.
    PubMed    
    Abstract available

  238. SHAMI S, Coombs J
    Cervical cancer screening guidelines: An update.
    JAAPA. 2021;34:21-24.
    PubMed    
    Abstract available

  239. CASTLE PE
    Letter to the Editor Re: A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.
    Cancer Med. 2021 Aug 26. doi: 10.1002/cam4.4240.
    PubMed    


  240. DRETCANU G, Iuhas CI, Diaconeasa Z
    The Involvement of Natural Polyphenols in the Chemoprevention of Cervical Cancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  241. LIU Z, Chen H, Lv F, Wang J, et al
    Sequential Release of Paclitaxel and Imatinib from Core-Shell Microparticles Prepared by Coaxial Electrospray for Vaginal Therapy of Cervical Cancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  242. KIM L, Park SA, Park H, Kim H, et al
    Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  243. PHAM CH, Lee JE, Yu J, Lee SH, et al
    Anticancer Effects of Propionic Acid Inducing Cell Death in Cervical Cancer Cells.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  244. CHONG GO, Park SH, Jeong SY, Kim SJ, et al
    Prediction Model for Tumor Budding Status Using the Radiomic Features of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Cervical Cancer.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  245. CHAROENKWAN P, Shoombuatong W, Nantasupha C, Muangmool T, et al
    iPMI: Machine Learning-Aided Identification of Parametrial Invasion in Women with Early-Stage Cervical Cancer.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  246. TRZESZCZ M, Mazurec M, Jach R, Mazurec K, et al
    Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  247. TRYBUS W, Krol T, Trybus E, Stachurska A, et al
    Physcion Induces Potential Anticancer Effects in Cervical Cancer Cells.
    Cells. 2021;10.
    PubMed    
    Abstract available

  248. MARTINEZ-RODRIGUEZ F, Limones-Gonzalez JE, Mendoza-Almanza B, Esparza-Ibarra EL, et al
    Understanding Cervical Cancer through Proteomics.
    Cells. 2021;10.
    PubMed    
    Abstract available

  249. KHAN F, Pandey P, Jha NK, Khalid M, et al
    Rutin Mediated Apoptotic Cell Death in Caski Cervical Cancer Cells via Notch-1 and Hes-1 Downregulation.
    Life (Basel). 2021;11.
    PubMed    
    Abstract available

  250. PARK BK, Kim TJ
    Useful MRI Findings for Minimally Invasive Surgery for Early Cervical Cancer.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  251. CAFFORIO P, Palmirotta R, Lovero D, Cicinelli E, et al
    Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  252. BEDDOE AM
    Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced.
    JCO Glob Oncol. 2021;7:1327-1328.
    PubMed    


  253. BAI H, Song M, Jiao R, Li W, et al
    DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.
    J Cell Mol Med. 2021 Aug 26. doi: 10.1111/jcmm.16865.
    PubMed    
    Abstract available

  254. OHTA T, Nagase S, Okui Y, Enomoto T, et al
    Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan.
    Int J Clin Oncol. 2021 Aug 25. pii: 10.1007/s10147-021-02017.
    PubMed    
    Abstract available

  255. NAKAMURA H, Ko K, Kiseki H, Ikeda SI, et al
    Renal Subcapsular Hematoma Formation Due to Hydronephrosis Caused by Recurrent Uterine Cervical Cancer.
    J Med Cases. 2021;12:126-129.
    PubMed    
    Abstract available

  256. MILLER H, Matsuo K, Roman LD, Yessaian AA, et al
    Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.
    Radiat Oncol. 2021;16:162.
    PubMed    


  257. KIM YA, Yang MS, Park M, Choi MG, et al
    Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea.
    J Gynecol Oncol. 2021 Jul 16. pii: 32.e85. doi: 10.3802/jgo.2021.
    PubMed    
    Abstract available

  258. DI DONATO V, Caruso G, Sassu CM, Santangelo G, et al
    Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review.
    J Gynecol Oncol. 2021 Aug 4. pii: 32.e83. doi: 10.3802/jgo.2021.
    PubMed    
    Abstract available

  259. YANG H, Zhang Y, Liu C, Feng B, et al
    The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapy.
    Ann Transl Med. 2021;9:1184.
    PubMed    
    Abstract available

  260. MORTENSEN JH, Bigaard J, Kvernrod AB
    Young Danish HPV vaccinated women's knowledge, barriers and facilitators towards cervical cancer screening: A qualitative study.
    Prev Med Rep. 2021;24:101507.
    PubMed    
    Abstract available

  261. HARPER DM, Tariq M, Alhawli A, Syed N, et al
    Cancer risk perception and physician communication behaviors on cervical cancer and colorectal cancer screening.
    Elife. 2021;10.
    PubMed    
    Abstract available

  262. CHU R, Zhang Y, Qiao X, Xie L, et al
    Risk stratification of early-stage cervical cancer with intermediate-risk factor: model development and validation based on machine learning algorithm.
    Oncologist. 2021 Aug 24. doi: 10.1002/onco.13956.
    PubMed    
    Abstract available

  263. ERBIYIK HI, Palalioglu RM
    HPV Infection, HPV Vaccines and Cervical Cancer Awareness: A Multi-Centric Survey Study in Istanbul, Turkey.
    Women Health. 2021 Aug 23:1-12. doi: 10.1080/03630242.2021.1969612.
    PubMed    
    Abstract available

  264. MAGUIRE FB, Cooley JJP, Morris CR, Parikh-Patel A, et al
    Symptomatic presentation of cervical cancer in emergency departments in California.
    Cancer Causes Control. 2021 Aug 23. pii: 10.1007/s10552-021-01489.
    PubMed    
    Abstract available

  265. YAN G, Kang S, Tang B, Li J, et al
    Effect of the dwell time deviation constraint on brachytherapy treatment planning for cervical cancer.
    J Int Med Res. 2021;49:3000605211037477.
    PubMed    
    Abstract available

  266. CHEN X, He H, Xiao Y, Hasim A, et al
    CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways.
    Front Oncol. 2021;11:629350.
    PubMed    
    Abstract available

  267. ENEBE JT, Enebe NO, Agunwa CC, Nduagubam OC, et al
    Awareness, acceptability and uptake of cervical cancer vaccination services among female secondary school teachers in Enugu, Nigeria: a cross-sectional study.
    Pan Afr Med J. 2021;39:62.
    PubMed    
    Abstract available

  268. SAI C, Qin W, Meng J, Gao LN, et al
    Macleayins A From Macleaya Promotes Cell Apoptosis Through Wnt/beta-Catenin Signaling Pathway and Inhibits Proliferation, Migration, and Invasion in Cervical Cancer HeLa Cells.
    Front Pharmacol. 2021;12:668348.
    PubMed    
    Abstract available

  269. OKEDO-ALEX IN, Akamike IC, Uneke CJ
    Does Spousal Engagement Improve Cervical Cancer Screening Discussions and Uptake? Lessons from a Before-After Study in a Rural Nigerian Community.
    J Health Care Poor Underserved. 2021;32:1566-1583.
    PubMed    
    Abstract available

  270. EFFAH K, Amuah JE, Dunyo P, Akwada G, et al
    Raising Funds Through Social Media to Subsidise Cervical Cancer Screening with HPV Testing in Rural Ghana-The Battor Experience.
    J Health Care Poor Underserved. 2021;32:1136-1144.
    PubMed    
    Abstract available

  271. CHEN LM, Zhang HW, Wang Q, Li Q, et al
    [Application of vaginoscopy in the diagnosis and treatment of occult vaginal high-grade squamous intraepithelial lesions].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:569-575.
    PubMed    
    Abstract available

  272. WANG D, Yang B, Wang W, Liu X, et al
    Higher dose to organs at risk: The unintended consequences of intravenous contrast use in CT simulation for cervical cancer.
    Pract Radiat Oncol. 2021 Aug 19. pii: S1879-8500(21)00210.
    PubMed    
    Abstract available

  273. DIAZ DE LEON-MARTINEZ L, Flores-Ramirez R, Miguel Lopez-Mendoza C, Rodriguez-Aguilar M, et al
    Identification of Volatile Organic Compounds in the urine of patients with Cervical Cancer. Test concept for timely screening.
    Clin Chim Acta. 2021 Aug 18. pii: S0009-8981(21)00292.
    PubMed    
    Abstract available

  274. GROVES S, Brooks J
    What do young women below national screening age in England think about cervical cancer and cervical screening? A qualitative study.
    J Clin Nurs. 2021 Aug 21. doi: 10.1111/jocn.16012.
    PubMed    
    Abstract available

  275. CHEN C, Xu Y, Huang W, Du Y, et al
    Natural history of histologically confirmed high-grade cervical intraepithelial neoplasia during pregnancy: meta-analysis.
    BMJ Open. 2021;11:e048055.
    PubMed    
    Abstract available

  276. JACQUOT A, Chauleur C, Russel-Robillard AS, Tinquaut F, et al
    MRI accuracy and interobserver agreement in locally advanced cervix carcinoma.
    Br J Radiol. 2021 Jul 8:20210197. doi: 10.1259/bjr.20210197.
    PubMed    
    Abstract available

  277. MANGANARO L, Nicolino GM, Dolciami M, Martorana F, et al
    Radiomics in cervical and endometrial cancer.
    Br J Radiol. 2021 Jul 8:20201314. doi: 10.1259/bjr.20201314.
    PubMed    
    Abstract available

  278. MSAMI K, Mbwana M, Mwaiselage J, Nyagabona S, et al
    Developing Research Education Groups in African Cancer Centers: The Experience in Tanzania.
    J Cancer Educ. 2021;36.
    PubMed    
    Abstract available

  279. IND T
    Radical vaginal trachelectomy.
    Best Pract Res Clin Obstet Gynaecol. 2021;75:65-71.
    PubMed    
    Abstract available

  280. OCADIZ-DELGADO R, Serafin-Higuera N, Alvarez-Rios E, Garcia-Villa E, et al
    Vitamin A deficiency in K14E7HPV expressing transgenic mice facilitates the formation of malignant cervical lesions.
    APMIS. 2021;129:512-523.
    PubMed    
    Abstract available

  281. KIDO A, Nakamoto Y
    Implications of the new FIGO staging and the role of imaging in cercal cancer.
    Br J Radiol. 2021 May 14:20201342. doi: 10.1259/bjr.20201342.
    PubMed    
    Abstract available

  282. SALVO G, Pareja R, Ramirez PT
    Minimally invasive radical trachelectomy: Considerations on surgical approach.
    Best Pract Res Clin Obstet Gynaecol. 2021;75:113-122.
    PubMed    
    Abstract available

  283. COTRIM ACM, Franca EL, Martins JS, Silva KPG, et al
    Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus.
    Cancer Immunol Immunother. 2021;70:2721-2726.
    PubMed    
    Abstract available

  284. YAMADA I, Oshima N, Miyasaka N, Wakana K, et al
    Texture Analysis of Apparent Diffusion Coefficient Maps in Cervical Carcinoma: Correlation with Histopathologic Findings and Prognosis.
    Radiol Imaging Cancer. 2020;2:e190085.
    PubMed    
    Abstract available

  285. DESOUZA NM
    Imaging to assist fertility-sparing surgery.
    Best Pract Res Clin Obstet Gynaecol. 2021;75:23-36.
    PubMed    
    Abstract available

  286. ZHANG Q, Lu QB
    New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers.
    Sci Rep. 2021;11:788.
    PubMed    
    Abstract available

  287. ALSOUS MM, Ali AA, Al-Azzam SI, Abdel Jalil MH, et al
    Knowledge and awareness about human papillomavirus infection and its vaccination among women in Arab communities.
    Sci Rep. 2021;11:786.
    PubMed    
    Abstract available

  288. YAN L, Yang J, Long X, Zhou D, et al
    Epidemiological Characteristics of Human Papillomavirus (HPV) Infection in Different Groups of Women in Chongqing, China.
    Jpn J Infect Dis. 2021;74:369-372.
    PubMed    
    Abstract available

  289. ISNARD C, Seta V, Cesbron E, Bergeron C, et al
    Human papillomavirus-induced lesions of the anogenital tract among women with vulvar high-grade squamous intraepithelial lesions.
    J Am Acad Dermatol. 2021;84:1749-1750.
    PubMed    


  290. MABUCHI S, Niiro E, Nagayasu M
    The Development of a New Uterine Manipulation Method during Minimally Invasive Radical Hysterectomy.
    J Minim Invasive Gynecol. 2021;28:1000-1005.
    PubMed    
    Abstract available

  291. SANCER O, Sirin MC, Aridogan B, Sesli Cetin E, et al
    Comparison of DNA damage and proliferative capacities in smear samples of HPV positive and negative patients by micronucleus counting and AgNOR staining.
    Biotech Histochem. 2021;96:354-358.
    PubMed    
    Abstract available

  292. ANDERSSON S, Belkic K, Mints M, Ostensson E, et al
    Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
    J Cancer Educ. 2021;36:126-133.
    PubMed    
    Abstract available

  293. KASUGA Y, Ikenoue S, Tanaka Y, Tamagawa M, et al
    Expectant management for early pregnancy miscarriage after radical trachelectomy: a single-hospital-based study.
    Acta Obstet Gynecol Scand. 2021 Apr 2. doi: 10.1111/aogs.14158.
    PubMed    
    Abstract available

  294. RIVERA-COLON G, Chen H, Molberg K, Niu S, et al
    PD-L1 Expression in Endocervical Adenocarcinoma: Correlation With Patterns of Tumor Invasion, CD8+ Tumor-infiltrating Lymphocytes, and Clinical Outcomes.
    Am J Surg Pathol. 2021;45:742-752.
    PubMed    
    Abstract available

  295. LIN S, Gao K, Gu S, You L, et al
    Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years.
    Cancer. 2021 Aug 9. doi: 10.1002/cncr.33795.
    PubMed    
    Abstract available

  296. IKEGAMI K, Watanabe G, Kumagai J, Fujii Y, et al
    The apparition macrophage and Doderlein bacillus is negatively correlated in class I Papanicolaou smear: A morphological examination.
    Diagn Cytopathol. 2020 Jul 6. doi: 10.1002/dc.24538.
    PubMed    
    Abstract available

  297. SANTOS THULER LC, Reis Wariss B, Nogueira-Rodrigues A, de Melo AC, et al
    The utility of pretreatment systemic inflammatory response biomarkers on overall survival of cervical cancer patients stratified by clinical staging.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:281-288.
    PubMed    
    Abstract available

  298. MURAKAMI N, Ando K, Murata M, Murata K, et al
    Why not de-intensification for uterine cervical cancer?
    Gynecol Oncol. 2021 Jul 19. pii: S0090-8258(21)00583.
    PubMed    
    Abstract available

  299. TIWARI R, Narayanan GS, Reddy VP, Vishwanathan B, et al
    Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Gynecol Oncol. 2021 Jul 22. pii: S0090-8258(21)00585.
    PubMed    
    Abstract available

  300. HRUDA M, Robova H, Rob L, Halaska MJ, et al
    Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Oncological outcomes.
    Gynecol Oncol. 2021 Jul 27. pii: S0090-8258(21)00593.
    PubMed    
    Abstract available

  301. KIM J, Cho Y, Kim N, Chung SY, et al
    Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Gynecol Oncol. 2021;160:735-741.
    PubMed    
    Abstract available

  302. LI N, Hu Y, Zhang X, Liu Y, et al
    DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
    Int J Cancer. 2021;148:1768-1777.
    PubMed    
    Abstract available

  303. GREEN LI, Mathews CS, Waller J, Kitchener H, et al
    Attendance at early recall and colposcopy in routine cervical screening with human papillomavirus testing.
    Int J Cancer. 2021;148:1850-1857.
    PubMed    
    Abstract available

  304. KEANE A, Ng CW, Simms KT, Nguyen D, et al
    The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of HPV screening with self-collection and digital registry support.
    Int J Cancer. 2021 Aug 7. doi: 10.1002/ijc.33759.
    PubMed    
    Abstract available

  305. NKWABONG E, Kengne B, Nkene Mawamba Y, Sando Z, et al
    Influence of the human immunodeficiency virus on cervical precancerous lesions.
    Int J Gynaecol Obstet. 2021;154:540-543.
    PubMed    
    Abstract available

  306. JELINEK K, Harding L, Briceno R, Li Z, et al
    Prevalence of high-risk human papillomavirus genotypes in two regions of Peru.
    Int J Gynaecol Obstet. 2021;154:544-549.
    PubMed    
    Abstract available

  307. BORIA F, Chiva L, Zanagnolo V, Querleu D, et al
    Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.
    Int J Gynecol Cancer. 2021 Jul 28. pii: ijgc-2021-002587.
    PubMed    
    Abstract available

  308. GROVER S, Ning MS, Bale M, Lichter KE, et al
    Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
    Int J Gynecol Cancer. 2021 Jul 26. pii: ijgc-2021-002601.
    PubMed    
    Abstract available

  309. LUVIAN-MORALES J, Flores-Cisneros L, Jimenez-Lima R, Alarcon-Barrios S, et al
    Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
    Int J Gynecol Cancer. 2021 Aug 5. pii: ijgc-2021-002720.
    PubMed    
    Abstract available

  310. FONSECA BO, Possati-Resende JC, Salcedo MP, Schmeler KM, et al
    Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
    Obstet Gynecol. 2021;137:1043-1053.
    PubMed    
    Abstract available

  311. KIM JY, Lee DW, Kim MJ, Shin JE, et al
    Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018).
    BMC Cancer. 2021;21:880.
    PubMed    
    Abstract available

  312. HANSEN BT, Campbell S, Nygard M
    Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study.
    BMC Cancer. 2021;21:935.
    PubMed    
    Abstract available

  313. WU B, Xi S
    Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    BMC Cancer. 2021;21:928.
    PubMed    
    Abstract available

  314. BONI SP, Gnahatin F, Comoe JC, Tchounga B, et al
    Barriers and facilitators in cervical cancer screening uptake in Abidjan, Cote d'Ivoire in 2018: a cross-sectional study.
    BMC Cancer. 2021;21:952.
    PubMed    
    Abstract available

  315. WIIK J, Nilsson S, Karrberg C, Strander B, et al
    Associations of treated and untreated human papillomavirus infection with preterm delivery and neonatal mortality: A Swedish population-based study.
    PLoS Med. 2021;18:e1003641.
    PubMed    
    Abstract available

  316. HOPKINS KL, Jaffer M, Hlongwane KE, Otwombe K, et al
    Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    PLoS One. 2021;16:e0255124.
    PubMed    
    Abstract available

  317. TERMRUNGRUANGLERT W, Khemapech N, Vasuratna A, Havanond P, et al
    The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand.
    PLoS One. 2021;16:e0245894.
    PubMed    
    Abstract available

  318. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed    
    Abstract available

  319. KEETILE M, Ndlovu K, Letamo G, Disang M, et al
    Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
    PLoS One. 2021;16:e0255581.
    PubMed    
    Abstract available

  320. ST-MARTIN G, Viborg PH, Andersen ABT, Andersen B, et al
    Histological outcomes in HPV-screened elderly women in Denmark.
    PLoS One. 2021;16:e0246902.
    PubMed    
    Abstract available

  321. PONCET L, Panjo H, Ringa V, Andro A, et al
    Do vulnerable groups access prevention services? Cervical cancer screening and HIV testing among homeless migrant women in the Paris metropolitan area.
    PLoS One. 2021;16:e0255900.
    PubMed    
    Abstract available

  322. SUCHONSKA B, Gajzlerska-Majewska W, Wielgos M
    Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations.
    PLoS One. 2021;16:e0247702.
    PubMed    
    Abstract available

  323. SUNDSTROM K, Lamin H, Dillner J
    Validation of the cobas 6800 human papillomavirus test in primary cervical screening.
    PLoS One. 2021;16:e0247291.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;